The remaining two studies found that diabetic therapies such as Exenatide or a combination of Metformin and Exenatide achieve better insulin sensitivity and a higher rate of remission of prediabetes compared to Metformin alone among women with PCOS [34,37]. Here, INS is linked to prediabetes syndrome.